| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.87▼ | 3.87▼ | 3.87▼ | 3.74▼ | 4.89▼ |
| MA10 | 3.96▼ | 3.96▼ | 3.98▼ | 3.99▼ | 2.66▲ |
| MA20 | 4.17▼ | 4.22▼ | 4.34▼ | 5.36▼ | 1.66▲ |
| MA50 | 5.27▼ | 5.65▼ | 4.77▼ | 2.53▲ | 1.20▲ |
| MA100 | 3.86▼ | 3.09▲ | 2.60▲ | 1.63▲ | 1.24▲ |
| MA200 | 2.15▲ | 1.83▲ | 1.63▲ | 1.24▲ | 1.24▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.031▼ | -0.104▼ | -0.404▼ | 0.379▲ |
| RSI | 26.812▼ | 26.998▼ | 28.542▼ | 45.750▼ | 60.193▲ |
| STOCH | 17.251▼ | 14.899▼ | 8.388▼ | 3.211▼ | 56.650 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -54.414 |
| CCI | -232.479▼ | -213.889▼ | -167.616▼ | -75.012 | 43.173 |
|
Friday, October 02, 2026 05:30 AM
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative ...
|
|
Wednesday, September 30, 2026 05:00 PM
Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, September 10, 2026 02:11 PM
Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/10/26 | 3.555 | 3.555 | 3.555 | 3.555 | 3,101 |
| 09/10/26 | 3.6135 | 3.85 | 3.6135 | 3.66 | 15,607 |
| 08/10/26 | 3.82 | 3.8979 | 3.561 | 3.58 | 15,850 |
| 07/10/26 | 3.95 | 4.07 | 3.79 | 3.82 | 12,891 |
| 06/10/26 | 4.03 | 4.33 | 3.94 | 4.07 | 17,784 |
| 05/10/26 | 4.06 | 4.54 | 3.96 | 4.03 | 12,245 |
| 02/10/26 | 3.97 | 4.01 | 3.82 | 3.935 | 24,230 |
| 01/10/26 | 4.37 | 4.37 | 3.8274 | 4.05 | 51,913 |
| 30/09/26 | 4.71 | 4.7425 | 4.00 | 4.43 | 40,386 |
| 29/09/26 | 5.04 | 5.54 | 4.355 | 4.78 | 35,864 |
|
|
||||
|
|
||||
|
|